Senti Biosciences, Inc.SNTINASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-50.28M
↓ 11% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-45.47M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-50.28M | -21.4% |
| 2024 | $-41.42M | +35.7% |
| 2023 | $-64.43M | +15.5% |
| 2022 | $-76.27M | -89.8% |
| 2021 | $-40.18M | -58.6% |
| 2020 | $-25.33M | -24.3% |
| 2019 | $-20.37M | - |